References
- NIH News Release: NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit. NHLBI Communications Office, Tuesday, July 9, 2002
- Rossouw JE, Anderson GL, Prentice RL, . for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
- Utian WH. Managing menopause after HERS II and WHI: coping with the aftermath. Menopause Management 2002;11:6–7
- Utian WH. Personal perspective. NIH and WHI – time for a mea culpa and steps beyond. Menopause 2007;14:1056–9
- Utian WH. Thoughts on suffering and dying – or, is ‘disease A’ really equivalent to ‘disease B’? Menopause Management 2004;13:9–10
- Anderson GL, Judd HL, Kaunitz AM, . for the WHI Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. JAMA 2003;290:1739–48
- Anderson GL, Judd HL, Kaunitz AM, . Hormone therapy and risk of gynecologic cancer. JAMA 2004;29:43
- Shumaker S, Legault C, Rapp S, . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651–62
- Rossouw JE, Prentice RL, Manson JE, . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–77
- Manson JE, Allison MA, Rossouw JE, . Estrogen therapy and coronary artery calcification. N Engl J Med 2007;356:2591–602
- Hodis HN. Commentary on the WHI Coronary-Artery Calcium Study of Manson, et al. (ref 5). North American Menopause Society First to Know electronic newsletter, 2007 (June):2–4
- Women's Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
- Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a large health management organization. Menopause 2011;18:1172–7
- The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2012 position statement of The North American Menopause Society. Menopause 2012; 19:257–71
- Parker-Pope T. How NIH misread hormone study in 2002. Wall Street J July 9, 2007:B1
- Rossouw JE, Stefanick ML. We stand by data on heart disease risk in estrogen drug study. Wall Street J July 21 2007:A5
- Utian WH. Hormone therapy and risk of gynecologic cancers. JAMA 2004;291:42–3
- Anderson G, LaCroix A, Limacher M, . WHI Investigators letter to the editor. Menopause 2012;19. Epub ahead of print. Accessed June 8, 2012. DOI: 10.1097/gme.0b013e3182594f76
- Gass M, Manson J, Stuenkel C, . Response to WHI Investigators’ letter to the editor 2012 - 03-13. Menopause 2012;19. Epub ahead of print. Accessed June 8, 2012. DOI: 10.1097/gme. 0b013e31825b32ea